Protara Therapeutics (TARA) Other financing activities (2020 - 2024)

Protara Therapeutics' Other financing activities history spans 6 years, with the latest figure at $385000.0 for Q1 2024.

  • Quarterly Other financing activities fell 69.47% to $385000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Mar 2024, down 21.58% year-over-year, with the annual reading at $4.9 million for FY2023, 9.81% down from the prior year.
  • Other financing activities came in at $385000.0 for Q1 2024, down from $1.2 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $7.4 million in Q4 2020 to a low of $368000.0 in Q1 2020.
  • The 5-year median for Other financing activities is $1.3 million (2023), against an average of $1.5 million.
  • The largest YoY upside for Other financing activities was 290.49% in 2021 against a maximum downside of 81.62% in 2021.
  • Protara Therapeutics' Other financing activities stood at $7.4 million in 2020, then crashed by 81.62% to $1.4 million in 2021, then dropped by 15.46% to $1.1 million in 2022, then grew by 0.96% to $1.2 million in 2023, then tumbled by 66.78% to $385000.0 in 2024.
  • Per Business Quant, the three most recent readings for TARA's Other financing activities are $385000.0 (Q1 2024), $1.2 million (Q4 2023), and $1.2 million (Q3 2023).